Sleeve Gastrectomy, Antiobesity Drugs Underutilized Sleeve Gastrectomy, Antiobesity Drugs Underutilized
Despite the increasing rate of obesity in the United States, sleeve gastrectomy and postoperative antiobesity pharmacotherapy remain significantly underused, according to investigators.Medscape Medical News
Condition: Morbid Obesity Intervention: Procedure: sleeve gastrectomy with loop bipartition Sponsor: Minia University Recruiting
Recent data support the use of bariatric surgery in adolescents with severe obesity following unsuccessful non-surgical treatments. Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) have demonstrated...
Conditions: Bariatric Surgery; Micronutrient Deficiencies; Obesity Intervention: Procedure: Gastric Bypass, Sleeve Gastrectomy Sponsor: Region Östergötland Active, not recruiting
In the paper by Angrisani et al, the authors tackle an important question, namely; what are the long term outcomes regarding gastroesophageal reflux disease (GERD) in patients undergoing sleeve gastrectomy (SG) ? Many surgeons consider GERD to be the Achilles heel of the SG, and it is one of the main reasons for conversion of the SG to other procedures such as the gastric bypass . The last International Consensus Conference on SG demonstrated that over 50% of surgeons considered GERD to be a relative contrindication to the SG, and also that hiatal hernias (HH) should be repaired when encountered .
Gut hormones implicated in glucose and energy homeostasis is altered in obesity. Laparoscopic sleeve gastrectomy (LSG) is shown to generate changes in the gut hormone levels and induces weight loss. We have previously demonstrated that Endoscopic sleeve gastroplasty (ESG) results in good weight loss. However, the metabolic and physiological alteration after ESG needs further understanding.
Sleeve gastrectomy (SG) has become a well-standardized surgical treatment option for obesity. However, the rate of weight regain (WR) after SG in long-term follow-up is relatively high. This multicenter study is the first to evaluate the use of an Endoscopic Sleeve Gastroplasty (ESG) technique for the management of WR after SG including patients with overweight-obesity across the full BMI spectrum.
One-loop duodenal switch leads to weight loss and improvement or resolution of comorbidities similar to standard duodenal switch and it is technically less demanding
Gastric sleeve stenosis (GSS) is reported in 0.7%-4% of cases after sleeve gastrectomy. Two endoscopic balloon dilation techniques are available with no clear consensus on the therapeutic approach.
AbstractThis video shows the case of a 64-year-old morbidly obese woman, with a non-adjustable gastric band, who consulted for weight regain and gastroesophageal reflux disease (GERD) symptoms and was converted to Roux-en-Y gastric bypass (RYGB). The operative technique included extensive lysis of adhesions, complete band dissection, partial gastrectomy of the fundus and body due to band erosion and conversion to RYGB.
ConclusionCombined laparoscopic pouch resizing and distalization are safe and can lead to adequate weight loss. This technique allows the combination of an added restriction and malabsorption to the previous RYGB and could lead to an improved weight loss.